Polycystic Ovarian Syndrome
Study finds orlistat and metformin equally effective for treatment of PCOS
Published in OBGYN and Reproduction Week, April 18th, 2005
V. Jayagopal and colleagues, University of Hull, North Humberside, U.K., evaluated and compared "the effect of treatment with orlistat vs. metformin on the hormonal and biochemical features of patients with polycystic ovarian syndrome (PCOS)."
According to their report, "Twenty-one Caucasian women with PCOS [mean(±SEM) age 27±0.9 years and body mass index 36.7±3.3 kg/m2] participated in this prospective, randomized, open-labeled study. All subjects had an 8-week run-in period...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of OBGYN and Reproduction Week
More Articles from OBGYN and Reproduction Week
- Contraception
Only half of women requesting postpartum sterilization undergo the procedure - Hormone Replacement Therapy
Estradiol affects blood pressure response to orthostasis in healthy older women - Infertility
A body mass index that's too high or too low can affect ovulation - Obstetrics
Antibiotics for BV, Trichomonas don't prevent preterm birth in high-risk women - Osteoporosis
Follow-up treatment for osteoporosis after fracture is lacking - Abortion
Study compares women's preference for medical or surgical abortion - More from this issue of OBGYN and Reproduction Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
